Profile data is unavailable for this security.
About the company
Jinyu Bio-Technology Co Ltd is a China-based company primarily engaged in the research and development, production, and sale of veterinary biological products. The Company’s product portfolio covers four major series of animal vaccines for swine, avian, ruminants, and companion animal. The Company’s products are mainly used to prevent animal diseases such as foot-and-mouth disease, porcine circovirus disease, mycoplasmas pneumonia of swine, porcine reproductive and respiratory syndrome, pseudorabies, highly pathogenic avian influenza, brucellosis, bovine viral diarrhea or mucosal disease, lumpy skin disease, infectious bovine rhinotracheitis, feline triple vaccine, and rabies. The Company conducts its business in the domestic and overseas markets.
- Revenue in CNY (TTM)1.33bn
- Net income in CNY100.76m
- Incorporated1993
- Employees1.74k
- LocationJinyu Bio-Technology Co LtdNo. 58, Ordos West StreetHUHEHAOTE 010111ChinaCHN
- Phone+86 4 716539434
- Fax+86 4 718086060
- Websitehttps://www.jinyu.com.cn
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Guobang Pharma Ltd | 5.94bn | 872.95m | 15.87bn | 4.00k | 18.09 | 1.92 | -- | 2.67 | 1.57 | 1.57 | 10.68 | 14.80 | 0.5603 | 3.06 | 7.04 | 1,484,531.00 | 8.20 | 9.52 | 10.33 | 12.47 | 24.67 | 27.10 | 14.64 | 14.91 | 2.30 | -- | 0.1038 | 24.76 | 10.12 | 9.15 | 27.61 | 19.94 | -7.08 | -- |
| Zhejiang Jiuzhou Pharmaceutical Co Ltd | 5.36bn | 722.87m | 15.97bn | 5.00k | 22.13 | 1.82 | -- | 2.98 | 0.8113 | 0.8113 | 6.07 | 9.84 | 0.493 | 1.97 | 4.84 | 1,070,948.00 | 6.65 | 9.23 | 7.91 | 12.19 | 34.65 | 33.78 | 13.50 | 15.64 | 2.42 | -- | 0.0152 | 39.55 | -6.57 | 20.67 | -41.34 | 20.58 | 22.64 | 8.45 |
| China Resources Jingzhng Phrmctcl Co Ltd | 4.40bn | 837.30m | 16.12bn | 4.18k | 19.20 | 4.25 | -- | 3.67 | 1.32 | 1.32 | 6.94 | 5.98 | 0.6755 | 3.53 | 11.30 | 1,051,350.00 | 14.12 | 11.45 | 23.31 | 16.72 | 60.96 | 64.04 | 20.91 | 18.23 | 1.33 | -- | 0.0348 | 93.25 | -2.59 | 12.61 | 9.67 | 11.20 | 30.67 | 36.85 |
| Nanjing King-Frind Bchmcl Phrmctcl C Ltd | 3.76bn | 649.83m | 16.14bn | 1.36k | 24.49 | 2.39 | -- | 4.29 | 0.4079 | 0.4079 | 2.35 | 4.18 | 0.3812 | 0.6322 | 3.82 | 2,765,677.00 | 6.59 | 8.38 | 8.99 | 12.03 | 41.12 | 44.95 | 17.28 | 19.72 | 1.35 | -- | 0.2644 | 23.22 | -0.1984 | 9.70 | 536.09 | 6.43 | 34.44 | -6.04 |
| Jinyu Bio-Technology Co Ltd | 1.33bn | 100.76m | 17.22bn | 1.74k | 218.17 | 3.15 | -- | 12.98 | 0.071 | 0.071 | 1.27 | 4.92 | 0.1946 | 2.45 | 1.89 | 762,676.30 | 1.37 | 4.31 | 1.56 | 5.06 | 50.46 | 57.76 | 7.02 | 17.99 | 3.09 | -- | 0.0029 | 36.89 | -21.45 | 2.19 | -61.57 | -13.19 | -21.84 | -12.94 |
| Tonghua Dongbao Pharmaceutical Co Ltd | 2.74bn | 1.23bn | 17.41bn | 3.41k | 14.18 | 2.44 | -- | 6.35 | 0.6271 | 0.6271 | 1.40 | 3.64 | 0.3589 | 1.05 | 5.11 | 803,924.60 | 15.84 | 14.89 | 17.08 | 15.68 | 71.05 | 78.86 | 44.15 | 35.26 | 3.49 | -- | 0.0988 | 50.60 | -34.66 | -6.27 | -103.66 | -- | 14.17 | 4.56 |
| Shandong Buchang Pharmaceuticals Co Ltd | 10.96bn | 1.66m | 18.32bn | 7.69k | 2,546.92 | 1.73 | -- | 1.67 | 0.0068 | 0.0068 | 10.34 | 10.03 | 0.5519 | 0.9196 | 13.73 | 1,425,409.00 | -0.6503 | 0.8521 | -0.9366 | 1.25 | 62.31 | 70.57 | -1.18 | 1.32 | 0.4929 | 3.23 | 0.2758 | 157.32 | -16.91 | -5.04 | -273.62 | -- | -21.53 | -- |
| Liaoning Cheng Da Co Ltd | 11.12bn | 862.79m | 18.68bn | 3.32k | 21.24 | 0.6349 | -- | 1.68 | 0.575 | 0.575 | 7.27 | 19.23 | 0.2277 | 5.72 | 5.88 | 3,352,748.00 | 2.94 | 3.15 | 4.13 | 4.55 | 12.07 | 13.95 | 12.89 | 9.88 | 0.9357 | -- | 0.2586 | 16.44 | 4.70 | -8.65 | -10.09 | -29.33 | -9.31 | -27.52 |
Data as of Feb 10 2026. Currency figures normalised to Jinyu Bio-Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
4.85%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Guotai Asset Management Co., Ltd.as of 30 Jun 2025 | 15.95m | 1.42% |
| China Southern Asset Management Co., Ltd.as of 31 Mar 2025 | 8.40m | 0.75% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 6.50m | 0.58% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 6.45m | 0.58% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 5.11m | 0.46% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 2.87m | 0.26% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2025 | 2.78m | 0.25% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 2.63m | 0.24% |
| Tian Hong Asset Management Co., Ltd.as of 30 Jun 2025 | 1.96m | 0.18% |
| Dimensional Fund Advisors LPas of 08 Jan 2026 | 1.66m | 0.15% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
